The Global IVIG Industry Report 2014 is a professional and in-depth study on the current state of the global IVIG industry.
The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The IVIG market analysis is provided for the international markets including development trends, competitive landscape analysis, and key regions development status.
Development policies and plans are also discussed and manufacturing processes and cost structures analyzed. IVIG industry import/export consumption, supply and demand figures and cost price and production value gross margins are also provided.
The report focuses on thirty-seven industry players providing information such as company profiles, product picture and specification, capacity production, price, cost, production value and contact information. Upstream raw materials and equipment and downstream demand analysis is also carried out. The IVIG industry development trends and marketing channels are analyzed. Finally the feasibility of new investment projects are assessed and overall research conclusions offered.
With 219 tables and figures the report provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.
Key Topics Covered:
Chapter One IVIG Industry Overview
Chapter Two Global IVIG Market Status Analysis
Chapter Three Major Regions IVIG Market Status Analysis
Chapter Three Major Countries IVIG Market Status and Analysis
Chapter Five Major Companies IVIG Market Status and Analysis
Chapter Six IVIG Industry Chain and Marketing Channels Analysis
Chapter Seven IVIG Industry Segment Market Analysis
Chapter Eight IVIG Industry Development Trend
Chapter Nine IVIG New Project Investment Feasibility Analysis
Chapter Ten Global IVIG Industry Research Conclusions
- Beijing Tiantan Biological Products Co.Ltd.
- Chengdu Rongsheng Pharmaceuticals Co., Ltd.
- Green Cross (China) Biological Products Co., Ltd.
- Guangdong Shuanglin Bio-Pharmacy Co., Ltd.
- Guangdong Wei Lun bio-pharmaceutical company
- Guangxi Beisheng Pharmaceutical Co.,Ltd.
- Guizhou Taibang Biological Products Co.,Ltd
- Harbin Pacific Biopharmaceutical Co.,Ltd) (PAFC) of Haerbin
- Harbin Shiheng Bioengineering And Pharmaceutical Co., Ltd.
- Hualan Biological Engineering,Inc
- Jiangxi Boya Bio-pharmaceutical Co., Ltd.
- Lanzhou Institute of Biological Products Co.Ltd.
- Nanyue Bio-pharmaceutical Co., Ltd.
- National Vaccine & Serum Institute
- Sanjiu Bio-pharmaceutical Co.,Ltd.
- Shandong Taibang Biological Products Co.,Ltd.
- Shanghai Institute of Biological Products Co.Ltd.
- Shanghai RAAS blood products Limited by Share Ltd.
- Shanghai Xinxing Medicine Co. Ltd.
- Shanxi Kangbao Biological Product Co. Ltd.
- Shenzhen Weiguan biological products Limited by Share Ltd.
- Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd
- Tonrol Bio-Pharmaceutical Co.,Ltd.
- Unisplendour Guhan Group Corporation Ltd.
- Wuhan Institute of Biological Products Co.Ltd.
- Xian HuiTian Blood Products Co.,Ltd.
- Zhejiang Haikang Biological Products Co., Ltd.
- Zhengzhou Banghe.Bio-Pharmaceutical Co.,Ltd.
For more information visit http://www.researchandmarkets.com/research/dj7hn9/global_ivig
Media Contact: Laura Wood, +353-1-481-1716, email@example.com
SOURCE Research and Markets